Search registration

Save the date for Keller and Heckman’s 10th Annual E-Vapor, Nicotine, and Tobacco Law Symposium, taking place on May 4 – 5, 2026, in Las Vegas, NV, at the Paris Las Vegas hotel (right before the CHAMPS Trade Show)!

This two-day seminar is designed to provide in-depth knowledge on legal, regulatory, and scientific issues essential for tobacco, nicotine, and CBD/hemp product manufacturers, suppliers, distributors, and retailers. 

Join us in May to hear from our knowledgeable attorneys, scientists, and industry experts who will cover a variety of timely topics, specifically designed to help vapor, oral nicotine, and deemed tobacco product manufacturers stay in compliance with rapidly evolving federal, state, and global laws and policies. 

Registration for the symposium will launch in December 2025. Stay tuned for updates on the event page here.

For questions related to the program, please contact Emma Kyle at kyle@khlaw.com.

Update on EU Regulations of E-Vapor and Nicotine Pouches

Date: Thursday, 08 May 2025
Time: 4:30 PM – 5:30 PM CET | 10:30 AM – 11:30 AM EDT
Duration: 60 minutes
Cost: Complimentary
Registration: Click Here

Keller and Heckman LLP is pleased to announce a complimentary webinar, Update on EU Regulations of E-Vapor and Nicotine Pouches, hosted by the Tobacco & E-Vapor Practice Partner Ales Bartl and moderated by Partner Azim Chowdhury.

During this 60-minute webinar, Ales will discuss the rapidly changing landscape of e-vapor and nicotine pouches in the EU. This session will provide insight into:

  • Horizontal EU Regulations (Chemicals, Electronic Products, Batteries, etc.)
  • EU Tobacco Products Directive: Applicability, Latest Developments
  • National Requirements, Existing and Upcoming Restrictions
  • General Product Safety, Enforcement, Liability, Online Sales

Don’t miss out on this opportunity to stay on top of the latest e-vapor & nicotine pouch regulatory developments—register here to secure your spot.

This webinar will offer the option for live captioning, provided by Zoom.

On December 10, 2024, the U.S. Food and Drug Administration (FDA or the Agency) Center for Tobacco Products (CTP) advanced a proposal to set a maximum nicotine level in cigarettes and certain other combusted tobacco products. The Agency requested the White House Office of Management and Budget (OMB) expedite a proposed tobacco product standard in what has been characterized as a “last-ditch” effort to drastically reduce the nicotine content in cigarettes. If finalized, the rule will have significant implications for Big Tobacco and its stakeholders, as it seeks to make cigarettes and other combusted tobacco products minimally addictive or non-addictive. The proposed tobacco product standard would likely not apply to electronic nicotine delivery systems (ENDS) or modern oral nicotine products (e.g., pouches), which are not combusted tobacco products. FDA’s continued pursuit of the nicotine product standard for cigarettes comes after the commercial failure of the only MRTP-authorized, very low-nicotine cigarettes marketed by 22nd Century Group Inc. 

FDA’s authority to establish tobacco product standards comes from the Family Smoking Prevention and Tobacco Control Act (TCA), 21 U.S.C. 387g(a)(4), which authorizes FDA to issue such standards that are appropriate for the protection of the public health (APPH). With respect to nicotine yields, the TCA prohibits the Agency from “banning all cigarettes, all smokeless tobacco products, all little cigars, all cigars other than little cigars, all pipe tobacco, or all roll-your-own tobacco products; or … requiring the reduction of nicotine yields of a tobacco product to zero….” 21 U.S.C. 387g(d)(3). 

On March 15, 2018, during the first Trump Administration and following then-Commissioner Scott Gottlieb’s announcement of FDA’s Comprehensive Plan for Tobacco and Nicotine Regulation, FDA issued an advance notice of proposed rulemaking (ANPRM) (Docket FDA-2017-N-6189) seeking public comment on issues and questions related to a potential nicotine product standard. FDA sought comments on:

  • Whether the scope of the nicotine reduction standard should include only cigarettes or also other tobacco products such as Roll-Your-Own (RYO) tobacco, cigars, pipe tobacco, and water pipe tobacco;
  • The appropriate nicotine level, with studies suggesting that 0.5 mg per rod could be an effective threshold; and
  • Additional questions addressing implementation time frames, analytical testing methods, technical feasibility, and potential countervailing effects (e.g., illicit market growth, dual use, and product switching) 

See our detailed analysis of the ANPRM here: FDA Issues Advanced Notice of Proposed Rulemaking on Potentially Lowering Nicotine Levels in Combustible Cigarettes to Minimally or Non-Addictive Levels | The Continuum of Risk.

Nearly 8,000 comments were submitted. Industry stakeholders are concerned that the proposed nicotine limits would not be technically achievable and could have unintended consequences, such as fueling the growth of contraband and an unregulated black market for cigarettes. 

The proposal is currently under review by the OMB’s Office of Information and Regulatory Affairs (OIRA). However, it remains uncertain whether the Biden Administration will take any steps to advance the rule to a Notice of Proposed Rulemaking (NPRM) in its final days in office. Any future NPRM would again be open for public comment before finalization.

We will discuss this and other potential tobacco product standards at Keller and Heckman’s 2025 Annual E-Vapor and Tobacco Law Symposium on January 27-28, 2025, in Las Vegas, Nevada. Details and registration information can be found here.

We are excited to announce the agenda for Keller and Heckman’s 2025 E-Vapor and Tobacco Law Symposium, featuring Keynote Speaker, Dr. Brian King, Director of FDA’s Center for Tobacco Products (CTP). Click here to view the full program agenda.

Register now to join us Monday, January 27 – Tuesday, January 28, 2025, in Las Vegas, NV (right before TPE). You don’t want to miss this comprehensive seminar designed to provide in-depth knowledge on legal, regulatory, and scientific issues that are essential for tobacco, nicotine, and CBD/hemp product manufacturers, suppliers, distributors, and retailers.

This year’s program will feature new, timely topics specifically designed to help vapor and deemed tobacco product manufacturers stay in compliance with rapidly evolving laws and policies. Topics that will be discussed during the program include:

  • New legislation, regulation, and enforcement of ENDS and oral nicotine products, including the upcoming extension of the California flavor ban to online sales
  • FDA Litigation Update: Where does the industry stand with MDO challenges following the 5th Circuit and Chevron decisions, and the upcoming Supreme Court decision in Triton
  • New state laws (PMTA registries, local flavor bans, licensing requirements, and state enforcement actions, including AG subpoenas against vapor companies)
  • The role of ENDS flavors in smoking cessation: Evidence from longitudinal and cross-sectional studies
  • The importance of quantifying the risk to youth associated with your ENDS products
  • U.S. ITC: RJ Reynold’s PACT Act and patent challenges against disposables – what’s next?
  • PACT Act Compliance and Update on Increased Enforcement
  • FDA’s Tobacco Product Manufacturing Practices (TPMP) Rule
  • Upcoming Federal ban on menthol cigarettes and flavored cigars
  • FDA’s new guidance and proposed rulemakings
  • Enforcement update: How to protect your company and brand
  • U.S. Customs and Border Protection (CBP) Import Requirements for ENDS and Related Products
  • Premarket Tobacco Product Application (PMTA) and Substantial Equivalence (SE) Report strategies for small businesses
  • Marketing plans, post-market surveillance, and youth-access prevention strategies
  • FDA Remote Regulatory Assessments (RRAs) and inspections
  • EU, Canada, and global regulatory update for ENDS and nicotine pouches
  • Updates on CBD/hemp, Delta-8 THC, THCA, and cannabis regulation
  • Case study: Evidence of switching and cigarette reduction over time, label comprehension and usability, abuse liability, behavioral intentions, and risk perceptions in relation to a disposable ENDS in one tobacco and four non-tobacco flavor variant
  • …and much more!

SEMINAR DETAILS

Dates
Monday, January 27 – Tuesday, January 28, 2025

Registration Fees
Early-Bird Rate: $1,099 if registered by Friday, December 13, 2024
Standard Registration Rate: $1,199 if registered after December 13, 2024

Location
Hilton-Conrad Resorts World Las Vegas
3000 South Las Vegas Boulevard
Las Vegas, NV 89109

Click here to book your hotel room. Keller and Heckman has negotiated a preferred room rate of $125 per night, plus tax, and a $50 per night resort fee, at the Hilton-Conrad Resorts World Las Vegas hotel. Please book your room by Thursday, December 26, 2024, in order to take advantage of the negotiated room rate.

Group Discount
Register three or more people from the same company and receive 10% off the total registration fee. Contact kyle@khlaw.com for instructions on how to receive the discount.

Continuing Legal Education (CLE)
CLE credit is available, pending individual state approval.

Certificate of Attendance
All seminar attendees will be eligible to receive a certificate of attendance upon completion of the course.

Cancellation Policy
Cancellations are accepted, and registration fees are refunded if notice is received by December 26, 2024. If notice is given after December 26, no refunds will be granted; however, substitutions are welcome.

For questions concerning the 2025 E-Vapor and Tobacco Law Symposium, please contact:
Emma Kyle
Marketing and Events Coordinator
kyle@khlaw.com
202.434.4283

On August 28, 2024, the California legislature passed two laws – Assembly Bill 3218 (“AB 3218”) and Senate Bill 1230 (“SB 1230”) – that expand the scope of the state’s enforcement powers against flavored tobacco products. These laws, which have been signed by the Governor and are set to go into effect on January 1, 2025, will have a significant impact on the tobacco, nicotine, and vapor product industries.

Prohibition of Online Sales of Flavored Products

AB 3218 makes a seemingly minor, but very significant, change to Section 30101.7 of the California Revenue and Taxation Code, which outlines the conditions that tobacco product delivery sellers (i.e., online retailers that deliver products directly to adult California consumers) must meet to sell tobacco products in the state. The law adds an additional condition that provides that delivery sellers must comply with all “applicable state laws or local ordinances that impose[] restrictions on the retail sale of cigarettes or tobacco products directly to the public from a retail location . . . as if the delivery sales occurred entirely within the state and place.”

In short, this added provision will make online delivery sellers subject to the same restrictions as tobacco product retailers. Therefore, since the California flavor ban explicitly prohibits the sale of flavored tobacco products at brick-and-mortar retail stores and vending machines, once AB 3218 goes into effect, the sale of such products by delivery sellers will be treated as retail sales and, therefore, prohibited — closing the last remaining avenue to sell flavored tobacco products to California adult consumers.

Expanded Definition of Nicotine

Both AB 3218 and SB 1230 expand the definition of “nicotine” beyond tobacco-derived nicotine to include synthetically derived nicotine and nicotine analogs. Under the revised definition, nicotine will consist of “any form of the chemical nicotine, including any salt or complex, regardless of whether the chemical is naturally or synthetically derived, and includes nicotinic alkaloids and nicotine analogs.” We note that while this expanded definition pulls synthetic nicotine and nicotine analog products into the state flavor ban, this new definition appears to be limited to the flavor ban and, therefore, would not apply to California tax regulations.

Characterizing Flavor Expanded

Of note, both laws revise the definition of “characterizing flavor” to now capture “menthol sensation” products, which do not contain menthol flavor ingredients but typically contain synthetic cooling agents like WS-3. Characterizing flavor is now defined as any “taste or odor, distinguishable by an ordinary consumer either prior to or during the consumption of a tobacco product, other than the taste or odor of tobacco, including, but not limited to, tastes or odors relating to any fruit, chocolate, vanilla, honey, candy, cocoa, dessert, alcoholic beverage, menthol, mint, wintergreen, herb, or spice, or a cooling sensation distinguishable by an ordinary consumer during the consumption of a tobacco product.”

Unflavored Tobacco List

AB 3218 prohibits wholesalers, distributors, and delivery sellers from selling or attempting to sell tobacco products that are not listed on the “Unflavored Tobacco List” (“UTL”). The UTL, which will be published on the Attorney General’s website by December 31, 2025, will catalogue all tobacco products that lack characterizing flavor and are thus eligible for sale in California. Entities that sell or intend to sell unlisted products within the state may be fined up to $10,000 per violation.

While the Attorney General will promulgate the specific regulations implementing UTL, AB 3218 states that tobacco product manufacturers and importers will be required to report to the Attorney General the unflavored tobacco products that these entities manufacture or import for sale or distribution in California. Manufacturers and importers will have to follow reporting procedures similar to those in states that have passed PMTA directory regulations, “including the submission of an attestation signed under penalty of perjury that the product in question is unflavored.”

AB 3218 authorizes the Attorney General to issue fines (up to $50,000) against entities that report tobacco products as lacking a characterizing flavor if the entities did not have a reasonable basis to do so. The Attorney General will also have the power to charge reporting entities up to $1,000 for each product that they submit for UTL listing and for relisting applications.

CDTFA Authority

Both laws also authorize the California Department of Tax and Fee Administration (“CDTFA”) and other state or local law enforcement agencies to seize and, when appropriate, destroy flavored tobacco products from retailers that sold or intended to sell the products. Violators may also be fined $50 for each individual package of flavored tobacco products that was seized. AB 3218 makes wholesalers subject to the same treatment.

We will discuss these and other state laws and enforcement trends at Keller and Heckman’s 2025 Annual E-Vapor and Tobacco Law Symposium on January 27-28, 2025, in Las Vegas, Nevada. Details and registration information can be found here.

On October 16, 2024, the Oregon Court of Appeals in Bates v. Oregon Health Authority made a significant ruling by overturning a law restricting the packaging of e-cigarette and cannabis products on the grounds that the law is an unconstitutional restriction on free speech.

The law in question, ORS. 431A.175(2)(f), prohibited an “inhalant delivery system” [1] from being packaged “in a manner that is attractive to minors.” Subsequently, the Oregon Health Authority promulgated OAR 333-015-0357, which provided further elaboration on what is considered “attractive” to minors in product packaging by banning the use of:

  • Cartoons;
  • Celebrities, athletes, mascots, fictitious characters played by people, or other people likely to appeal to minors;
  • Food or beverages likely to appeal to minors, such as candy, desserts, soda, food or beverages with sweet flavors including fruit or alcohol;
  • Terms or descriptive words for flavors that are likely to appeal to minors, such as tart, tangy, sweet, cool, fire, ice, lit, spiked, Poppin’, juicy, candy, desserts, soda, sweet flavors, including fruit, or alcohol flavors; or
  • The shape of any animal, commercially recognizable toy, sports equipment, or commercially recognizable candy.

In addition to this comprehensive list of items explicitly prohibited from packaging, the rule includes a general catch-all restriction to include any presentation, shape, graphic, coloring, or writing that is likely to appeal to minors.

Plaintiffs Paul Bates and No Moke Daddy LLC (doing business as Division Vapor) argued that the packaging restrictions were overly broad and unconstitutionally vague and infringed on their right to free speech by prohibiting truthful, non-misleading communication. The Circuit Court denied the state constitutional challenge and dismissed the action. On appeal, the Oregon Court of Appeals reversed and remanded on grounds that the law violates free speech as outlined in Article I, Section VIII of the Oregon Constitution. 

The Court of Appeals explained that selling products is a form of communicative behavior that may involve protected speech. The Court stated that while there is nothing inherently expressive about packaging on its own, the law restricting “attractive” packaging is reasonably interpreted to refer to the communicative aspects of the packaging and not its functionality. Thus, the packaging restrictions are a direct restriction on expressive speech. In particular, the Court noted that the law is not based on the effect of the packaging (i.e., whether any children actually purchase the product as a result of the packaging), but rather turns on the substance of the expressive content.

In addition to this law, the vapor industry in Oregon is already subject to a wide variety of packaging requirements, including warning labels and child-resistant safety packaging for liquid nicotine containers.

We will discuss this and other state laws and enforcement trends at Keller and Heckman’s 2025 Annual E-Vapor and Tobacco Law Symposium on January 27-28, 2025, in Las Vegas, Nevada. Details and registration information can be found here.

[1] “Inhalant Delivery System” is defined as “a device that can be used to deliver nicotine or cannabinoids in the form of a vapor or aerosol to a person inhaling from the device”; or “A component of a device described in this subparagraph or a substance in any form sold for the purpose of being vaporized or aerosolized by a device described in this subparagraph, whether the component or substance is sold separately or is not sold separately.” See ORS 431A.175(1)(a)(A).

On September 5, 2024, the U.S Food and Drug Administration (“FDA”) and Centers for Diseases Control and Prevention (“CDC”) released data from the 2024 National Youth Tobacco Survey (“NYTS”), which shows the most remarkable decline in youth vaping to date. Specifically, the most recent NYTS, an annual, cross-sectional, web-based survey of U.S. middle school (grades 6-8) and high school (grades 9-12) students, indicates that the number of middle school (“MS”) and high school (“HS”) students reporting use of e-cigarettes or electronic nicotine delivery systems (“ENDS”) has declined to the lowest level in a decade. The 2024 NYTS was conducted among 29,861 HS and MS students from 283 schools between January 22 and May 22, 2024.   

NYTS Survey (Year)Percentage of High School Students Reporting Current E-Cigarette UseEstimated Weighted Number of High School Students Reporting Current E-Cigarette Use (Million)
20247.8%1.21
202310.0%1.56
202214.1%2.14
202111.3%1.72
202019.6%3.02
201927.5%4.11
  • The recent NYTS data show that the number of middle and high school students reporting current use of e-cigarettes in 2024 (1.63 million) constitutes only a fraction of the 2019 numbers (over 5 million – a large portion of which has been attributed to the rise of JUUL’s popularity at the time). See JUUL’s statement on the 2024 NYTS results here.
  • This trend has not slowed down in the past year, as the 2024 NYTS continues to demonstrate a downward trajectory for e-cigarettes. Significantly fewer middle school and high school students reported current e-cigarette use – from 2.13 million (7.7%) in 2023 to 1.63 million (5.9%) in 2024.
  • It is important to note that “current use” is defined by the NYTS to mean use on ≥1 day during the previous 30 days. In other words, a HS or MS student who vapes only once in the past month would be defined as a current user, regardless of their actual use or intention to use (or not use) the ENDS product in the future. Significantly, these numbers do not reflect daily use (i.e., use during all of the previous 30 days) or frequent use (as use on ≥20 days during the previous 30 days). In the NYTS publication, the authors include a disclaimer that these frequency of use estimates are not mutually exclusive. It is reasonable to assume that daily or frequent use would be a fraction of these “current use” numbers.
  • All in all, the data point to a continuing decline in youth use of the ENDS product category, given that half a million fewer youth are using e-cigarettes compared to last year’s data. FDA Center for Tobacco Products (“CTP”) Director Dr. Brian King described the “continued decline in e-cigarette use among our nation’s youth” as a “monumental public health win,” with an acknowledgment of the progress that has been made over the past half decade. 
  • Youth use of oral nicotine pouches was also highlighted in FDA’s press release, in which the Agency acknowledged that the numbers remained steady and low, with 1.5% of HS and MS students reporting current nicotine pouch use in 2023 and 1.8% in 2024. While the numbers are low, this comes with a caution that nearly half a million middle and high school students have still reported current nicotine pouch use. In fact, CDC makes it a point to state that, “[y]outh use of tobacco products in any form—including e-cigarettes and nicotine pouches—is unsafe,” quoting Deirdre Lawrence Kittner, Ph.D., M.P.H., director of CDC’s Office on Smoking and Health. This appears to be the first FDA NYTS news release that focuses its discussion of both e-cigarettes and nicotine pouches together as youth appealing tobacco products. In addition, FDA’s statement includes both a sub-title specifically addressing nicotine pouch results, as well as a dedicated paragraph on oral nicotine pouch numbers and brands used. Indeed, even the 2024 NYTS publication includes nicotine pouches in the publication title (“Notes from the Field: E-Cigarette and Nicotine Pouch Use Among Middle and High School Students — United States, 2024”).[1] All these factors suggest that pouches are top-of-mind for FDA when it comes to youth use.

We will discuss the potential impact of these data and enforcement trends and more at Keller and Heckman’s 2025 Annual E-Vapor and Tobacco Law Symposium on January 27-28, 2025, in Las Vegas, Nevada. Details and registration information can be found here.

[1] Park-Lee E, Jamal A, Cowan H, et al. Notes from the Field: E-Cigarette and Nicotine Pouch Use Among Middle and High School Students — United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:774–778. DOI: http://dx.doi.org/10.15585/mmwr.mm7335a3.

Save the date for Keller and Heckman’s 9th Annual E-Vapor and Tobacco Law Symposium, taking place on January 27 – 28, 2025, in Las Vegas, NV, right before the Total Product Expo (TPE)! This two-day seminar is designed to provide in-depth knowledge on legal, regulatory and scientific issues that are essential for tobacco, nicotine and CBD/hemp product manufacturers, suppliers, distributors and retailers. 

Join us in January to hear from our knowledgeable attorneys and scientists who will cover a variety of timely topics, specifically designed to help vapor and deemed tobacco product manufacturers stay in compliance with rapidly evolving laws and policies. 

Registration for this seminar, which will be held at the Hilton-Conrad Resorts World Las Vegas, will launch in September 2024.  In the meantime, for questions related to the program, please contact Emma Kyle at kyle@khlaw.com.

Keller and Heckman Partner Azim Chowdhury was interviewed for the Law360 article, “Product Liability Regulation And Legislation To Watch In 2024.” The article outlines a few different regulatory and legislative developments happening in 2024, including more enforcement in the e-cigarette industry. Azim noted that the industry will most likely see enforcement against unauthorized flavored disposable e-cigarettes from the U.S. Food and Drug Administration (FDA).

Additionally, the e-cigarette company Juul may finally receive decisions regarding their products from the FDA, which initially denied the applications for its tobacco- and menthol-flavored products. Juul also filed an application for a new tobacco-flavored device that has new features to prevent underage use, which the FDA has indicated interest in, according to Azim.

Juul has been blamed in the past for an increase in youth vaping rates; however, the 2023 National Youth Tobacco Survey reported a decline in high schoolers’ use of e-cigarettes, with 580,000 fewer students using them last year.

“Hopefully the trend continues and we see youth vaping continue to fall, and hopefully will translate into an FDA that’s more open to considering these products for adults,” commented Azim.

To read the full article, please click here (subscription required).

These topics and more will be covered at Keller and Heckman’s 2024 Annual E-Vapor and Tobacco Law Symposium. Be sure to save the date: January 29-30, 2024, in Las Vegas, Nevada. Details and registration information can be found here.

Keller and Heckman is pleased to announce the addition of a distinguished keynote speaker for the 2024 E-Vapor and Tobacco Law Symposium. Dr. Brian King, Director of FDA’s Center for Tobacco Products (CTP), will provide expert insight into current issues facing the industry. More information regarding this valuable keynote presentation will be available soon. In the meantime, we invite you to register now to secure your seat at this can’t-miss seminar!

Join us Monday, January 29 – Tuesday, January 30, 2024, in Las Vegas, NV (right before TPE). You don’t want to miss this comprehensive seminar focused on legal and regulatory issues critical to the ENDS, nicotine, tobacco, CBD/hemp, and cannabis industries. Click here to view the updated agenda!

This year’s program will feature new, timely topics specifically designed to help vapor and deemed tobacco product manufacturers stay in compliance with rapidly evolving laws and policies. Agenda highlights for the program include:

  • New legislation, regulation, and enforcement of nicotine products, including oral products and ENDS products
  • The role of ENDS flavors in smoking cessation: evidence from longitudinal and cross-sectional studies
  • The importance of quantifying the risk to youth associated with your ENDS products
  • Challenging RTAs, RTFs, MDOs, and NSEs – Can you still appeal your denial?
  • FDA Litigation Update: Where does the industry stand?
  • FDA’s new Tobacco Product Manufacturing Practices (TPMP) Rule
  • Upcoming Federal ban on menthol cigarettes and flavored cigars
  • FDA’s new guidance and proposed rulemakings
  • Enforcement Update: warning letters, civil money penalty orders, injunctions; strategies for responding and coming into compliance
  • Premarket Tobacco Product Application (PMTA) and Substantial Equivalence (SE) Report strategies for small businesses
  • Marketing plans, post-market surveillance, and youth-access prevention strategies
  • FDA Remote Regulatory Assessments and Inspections
  • Prevent All Cigarette Trafficking (PACT) Act – Key Updates
  • New state laws (local flavor bans, licensing requirements, and state enforcement actions)
  • Federal Communications Commission Requirements Rules Applicable to Vapor Products
  • Updates on CBD/hemp, Delta-8, and cannabis regulation
  • Mapping the global cannabis product landscape: Implications for Quality and Regulation
  • Global Regulatory Update: China, the EU, and the UK
  • …and much more!

SEMINAR DETAILS

Dates
Monday, January 29 – Tuesday, January 30, 2024

Registration Fees
Early-Bird Rate: $1,099 if registered by Friday, January 5, 2024
Standard Registration Rate: $1,199 if registered after January 5

Location
Embassy Suites by Hilton Convention Center Las Vegas
3600 Paradise Road
Las Vegas, NV 89169

Click here to book your hotel room. Keller and Heckman has negotiated a preferred room rate of $169 per night, plus tax, at the Embassy Suites by Hilton Convention Center Las Vegas. Please book your room by Friday, January 5, 2024, in order to take advantage of the negotiated room rate.

Group Discount
Register three or more people from the same company and receive 10% off the total registration fee. Contact maxwell@khlaw.com for instructions on how to receive the discount.

Continuing Legal Education (CLE)
CLE credit is available, pending individual state approval.

Certificate of Attendance
All seminar attendees will be eligible to receive a certificate of attendance upon completion of the course.

Cancellation Policy
Cancellations are accepted, and registration fees are refunded if notice is received by January 5, 2024. If notice is given after January 5, no refunds will be granted; however, substitutions are welcome.

For questions concerning the 2024 E-Vapor and Tobacco Law Symposium, please contact:

Abby Maxwell-Morrisroe
Marketing and Events Specialist
maxwell@khlaw.com
202.434.4223